CLINICAL_TRIALS
trial_result
· 2014-09-15
Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer [Phase 2]
Summary
A Phase 2 trial evaluating Herceptin (trastuzumab) in women with metastatic breast cancer has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-09-15